Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.

BACKGROUND: Statin therapy reduces the rates of heart attack, stroke, and revascularisation among a wide range of individuals. Reliable assessment of its cost-effectiveness in different circumstances is needed. METHODS: 20,536 adults (aged 40-80 years) with vascular disease or diabetes were randoml...

Bibliografske podrobnosti
Main Authors:	Mihaylova, B, Briggs, A, Armitage, J, Parish, S, Gray, A, Collins, R
Format:	Journal article
Jezik:	English
Izdano:	2005

Podobne knjige/članki

Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
od: Mihaylova, B, et al.
Izdano: (2005)

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
od: Mihaylova, B, et al.
Izdano: (2006)

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial.
od: Bulbulia, R, et al.
Izdano: (2011)

N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
od: Emberson, J, et al.
Izdano: (2005)

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
od: Armitage, J, et al.
Izdano: (2009)

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
od: Heart Protection Study Collaborative Group
Izdano: (2002)

N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
od: Emberson, J, et al.
Izdano: (2005)

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
od: Collins, R, et al.
Izdano: (2004)

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
od: Heart Protection Study Collaborative Group
Izdano: (2007)

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].
od: Group, H
Izdano: (2005)

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
Izdano: (2005-03-01)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
od: Emberson, JR, et al.
Izdano: (2007)

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
od: Collins, R, et al.
Izdano: (2002)

Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
od: Mihaylova, B, et al.
Izdano: (2009)

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
od: Collins, R, et al.
Izdano: (2003)

The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
od: Kent, S, et al.
Izdano: (2016)

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
od: Armitage, J, et al.
Izdano: (2010)

Regarding "Does simvastatin save lives; If so, when and in whom?" - Reply
od: Bulbulia, R, et al.
Izdano: (2008)

20536. COMPLICACIONES NEUROLÓGICAS PARENQUIMATOSAS EN LA ENFERMEDAD DE BEHÇET
od: E. Estrada Palma, et al.
Izdano: (2024-11-01)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
od: Mihaylova, B, et al.
Izdano: (2012)

Safety of long-term simvastatin discontinuation Reply
od: Bulbulia, R, et al.
Izdano: (2012)

Economic evaluation of the Heart Protection Study
od: Briggs, A, et al.
Izdano: (2003)

Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group.
od: Keech, A, et al.
Izdano: (1996)

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
od: Hopewell, J, et al.
Izdano: (2013)

Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials
od: Cholesterol Treatment Trialists' Collaboration, et al.
Izdano: (2019)

Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.
od: Harris, M, et al.
Izdano: (1995)

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
od: Hopewell, JC, et al.
Izdano: (2020)

Hospital costs associated with adverse events in people with diabetes in the UK
od: Keng, MJ, et al.
Izdano: (2022)

RPK 536 - PERANCANGAN PENGANGKUTAN FEB 01.
od: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Izdano: (2001)

RPK 536 – Transportation Planning - Jun 2013
od: PPPBP, Pusat Pengajian Perumahan Bangunan Dan Perancangan
Izdano: (2013)

RPK 536 - PERANCANGAN PENGANGKUTAN APRIL 1993.
od: PPPB, Pusat Pengajian Perumahan Bangunan & Perancangan (School of Houusing, Building & Planning)
Izdano: (1993)

RMK536 - PERANCANGAN PENGANKUTAN APRIL 1995
od: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Izdano: (1995)

RPK536 - PERANCANGAN PENGANGKUTAN FEBRUARI 1998
od: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Izdano: (1998)

RPK 536 — Perancangan Pengangkutan - Februari 2000
od: PPPBP, Pusat Pengajian Perumahan Bangunan Dan Perancangan
Izdano: (2000)

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.
od: Lara Jehi, et al.
Izdano: (2020-01-01)

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial
od: A. Agus, et al.
Izdano: (2017-05-01)

Antiaggregant impact of vascular wall on hemocyte in hypertension patients with dyslipidemia taking simvastatin
od: I A Skoryatina, et al.
Izdano: (2012-12-01)

PLG 536 - SAINS TEKNOLOGI & PENDIDIKAN OCT 04.
od: PPIP, Pusat Pengajian Ilmu Pendidikan
Izdano: (2004)

RTK 536 – Infrastructure And Tourism Services - Jun 2013
od: PPPBP, Pusat Pengajian Perumahan Bangunan Dan Perancangan
Izdano: (2013)

RPK 536 - PERANCANGAN PENGANGKUTAN MAC-APRIL 1991
od: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Izdano: (1991)